Prellis Biologics, Inc
Biotechnology company · San Francisco, California, United States
Prellis Biologics, Inc is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $460,000 sold in a notice filed in 2018.
Prellis Biologics at a glance
What does Prellis Biologics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $460,000 sold (2018).
Frequently asked questions about Prellis Biologics
Where is Prellis Biologics headquartered?
Prellis Biologics, Inc is headquartered in San Francisco, California, United States.
What does Prellis Biologics do?
Prellis Biologics, Inc is a biotechnology company.
When was Prellis Biologics founded?
The earliest incorporation on record for Prellis Biologics, Inc is in 2017, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences